ProCE Banner Activity

终结HIV流行:进步或停滞?

在COO艾滋病年会上这一热烈的小组讨论中,小组成员探讨了在美国终结HIV疫情的计划,包括对潜在的爆发风险进行早期诊断、快速响应等举措。

Released: April 14, 2021

Expiration: April 13, 2022

Share

Faculty

Michelle Cespedes

Michelle Cespedes, MD, MS

Professor of Medicine
Division of Infectious Disease
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco 
San Francisco, California

David A. Wohl

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by University of South Florida
ProCE Banner

Supporters

由来自……的教育资助金赞助

Merck Sharp & Dohme Corp.

ViiV Healthcare

Target Audience

该项目的目标受众为医生、临床药剂师、护士以及其他为HIV病毒感染者提供医疗服务的从业人员

Learning Objectives

Upon completion of this activity, participants should be able to:
  • 严格评估当前及未来的HIV病毒预防策略
  • 加强策略扩大检测,实现早期诊断
  • 了解最新临床研究结果和发展中的治疗指南,将其应用于ART一线药物的时机选择

Faculty Disclosure

Primary Author

Michelle Cespedes, MD, MS

Professor of Medicine
Division of Infectious Disease
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Michelle S. Cespedes, 医学博士,科学硕士,声明她接受了吉利德科学和ViiV公司的咨询费用。

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco 
San Francisco, California

Monica Gandhi, 医学博士,公共卫生硕士,无相关利益冲突需要声明。

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

David A. Wohl, 医学博士,声明他的研究曾接受吉利德科学、默克公司、和ViiV公司提供的资金支持,并且他曾获取吉利德科学、杨森制药、默克公司、和ViiV公司的咨询费用

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer M. Blanchette,博士,无相关利益冲突需要声明。

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright,博士,无相关利益冲突需要声明。

Tiffany Hensley-McBain, PhD

Clinical Editor

Tiffany Hensley-McBain,博士,无相关利益冲突需要声明。

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King,硕士,无相关利益冲突需要声明。

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran D. Mir-Hudgeons,博士,无相关利益冲突需要声明。

Anna Poppa,

Managing Editor, HIV
Clinical Care Options, LLC

Anna Poppa,无相关利益冲突需要声明。

Julie Skowronski, FNP-BC

Julie Skowronski,护士委员会认证家庭护理医师,无相关利益冲突需要声明。

Additional Information

Program Medium

This program has been made available online.

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:


Goal


这项活动通过聚焦HIV治疗领域的最新进展及诊所中遇到的关键问题,旨在加强临床医生解决HIV管理中最重要和最具挑战的问题的能力。